Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
When contemplating the administration of FOXO4-DRI, a senolytic peptide designed to target senescent cells, two distinct hypothetical dosing regimens come to the forefront, each with its unique scientific reasoning
Microdose Big Difference
With ongoing clinical trials and better peptide design, the goal is to increase success rates and decrease time to treatment
Consumers are no longer settling for generic products they want proven, effective formulations backed by science and real results
US$ 24.54
US$ 24.31
US$ 26.92
US$ 22.48
